European Commission's Pharmaceutical Sector Inquiry Report Finds Certain Practices May Delay Entry Of Generic Medicines.

Extract

---

European Commission's Pharmaceutical Sector Inquiry Report Finds Certain Practices May Delay Entry Of Generic Medicines.

On November 28, 2008, the European Commission published its preliminary report and findings in connection with the sector inquiry it launched late last year on competition in the pharmaceutical sector. The Commission acknowledges that patents are vital to providing pharmaceutical companies with an incentive to innovate and that patenting activities and litigation are generally legitimate. The report, nonetheless, concludes that "originator" companies (i.e., those that bring new products to market) have employed a "tool-box" of patent practices and product lifecycle strategies (e.g., multiple patent applications;...

See the full content of this document

---